Univest Financial’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.5M Buy
12,846
+2,852
+29% +$591K 0.12% 111
2026
Q1
$2.24M Buy
9,994
+876
+10% +$218K 0.13% 114
2025
Q4
$2.2M Buy
9,118
+382
+4% +$97.7K 0.12% 124
2025
Q3
$2.39M Sell
8,736
-68
-0.8% -$18.6K 0.13% 110
2025
Q2
$2.27M Sell
8,804
-2,439
-22% -$582K 0.14% 106
2025
Q1
$2.52M Sell
11,243
-4,595
-29% -$1.07M 0.16% 101
2024
Q4
$3.62M Buy
15,838
+1,470
+10% +$354K 0.23% 79
2024
Q3
$3.51M Buy
14,368
+12,515
+675% +$2.8M 0.23% 78
2024
Q2
$355K Buy
1,853
+629
+51% +$128K 0.1% 90
2024
Q1
$242K Buy
+1,224
New +$224K 0.07% 114

Other funds holding RMD

Univest Financial's RMD Position: Q2 2026 in Review

Univest Financial increased its ResMed (RMD) stake by 29% in Q2 2026, buying an estimated $591K and bringing the position to 12,846 shares worth $2.5M. The position accounts for 0.12% of the portfolio, ranked #111.

Univest Financial first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.62M in Q4 2024. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Univest Financial held 12,846 shares of ResMed worth $2.5M as of Q2 2026.
  • Univest Financial bought 2,852 ResMed shares in Q2 2026, an estimated $591K.
  • ResMed made up 0.12% of Univest Financial's portfolio in Q2 2026, its #111 holding.
  • Univest Financial first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
  • Univest Financial's ResMed position peaked at $3.62M in Q4 2024.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Univest Financial's 13F filing for Q2 2026, filed 7 Aug 2026.